We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

International Biotechnology Trust plc (IBT) Ordinary 25p Shares

Sell:696.00p Buy:700.00p 0 Change: No change
Market closed Prices as at close on 5 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:696.00p
Buy:700.00p
Change: No change
Market closed Prices as at close on 5 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:696.00p
Buy:700.00p
Change: No change
Market closed Prices as at close on 5 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
702.00p
Trade high:
708.00p
Year high:
734.00p
Estimated NAV:
804.92
Previous close:
698.00p
Trade low:
694.00p
Year low:
588.00p
Premium/Discount:
-13.28%
Previous:
12.00p (1.69%)
Previous:
12.00p
Volume:
30,616
Dividend yield:
4.04%
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
INT.BIOTECH. performance chart

Premium/Discount

INT.BIOTECH. performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 0.29% 1 year 1Y 17.11%
1 month 1M 1.9% 2 years 2Y 1.97%
3 months 3M 4.8% 3 years 3Y 3.59%
6 months 6M 8.72% 5 years 5Y 9.75%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: Nasdaq Biotechnology Index
Annual management charge: n/a
Performance fee: Yes
Ongoing charge: 1.35%
Dividend yield: 4.04%
Dividend frequency: Semi-Annually
Total assets: £324m
Gross gearing: 10%
Market capitalisation:Market cap.: £253m
Shares in issue: 36.28 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0004559349

Recent dividends paid or declared by International Biotechnology Trust plc:

Type Ex-div date Payment date Amount
2nd interim 25/07/2024 23/08/2024 14.50p
1st interim 21/12/2023 26/01/2024 13.90p
2nd interim 27/07/2023 25/08/2023 14.20p
1st interim 29/12/2022 27/01/2023 14.00p
2nd interim 04/08/2022 26/08/2022 15.70p

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual International Biotechnology Trust plc dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/08/2024 4.20% -0.32 28.40p
31/08/2023 4.40% -0.34 28.20p
31/08/2022 4.80% -0.23 31.40p
31/08/2021 3.90% -0.24 28.40p
31/08/2020 3.40% -0.23 24.80p

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

NET ASSET VALUE (NAV)

Estimated NAV: 804.92p
Latest actual NAV: 794.13p
Latest actual NAV date: 3 December 2024
Premium/Discount: -13.28%
12m average Premium/Discount: -10.05%
NAV frequency: Daily
Security Weight
Vera Therapeutics Inc Class A 6.38%
Intra-Cellular Therapies Inc 6.03%
Insmed Inc 4.64%
Supernus Pharmaceuticals Inc 3.96%
Sv Fund Vi Investment 3.65%
Sv Bcof 3.62%
Travere Therapeutics Inc Ordinary Shares 3.35%
Ascendis Pharma AS ADR 3.22%
Regeneron Pharmaceuticals Inc 2.95%
Biomarin Pharmaceutical Inc 2.92%
Sector Weight
Healthcare 102.19%
Country Weight
United States 84.03%
Denmark 4.97%
United Kingdom 3.56%
Netherlands 2.84%
Canada 2.05%
Spain 1.90%
Germany 1.42%
China 0.78%
Switzerland 0.30%
Sweden 0.26%

Key Dates

Launch date: 31 March 1994
Financial year end: August
Next AGM: December 2025
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.